PTS, Inc. Signs Agreement with Fisher HealthCare to Distribute CardioChek® Products

PTS, Inc. Signs Agreement with Fisher HealthCare to Distribute CardioChek® Products

Indianapolis, IN – October 25, 2012 – Polymer Technology Systems, Inc. (PTS, Inc.), the U.S.-based manufacturer of CardioChek point-of-care diagnostic products, has announced the signing of a multiyear distribution agreement with Fisher HealthCare (Fisher). Fisher HealthCare is part of Thermo Fisher Scientific Inc., an international company that serves customers within the pharmaceutical and biotech industries.

Per this agreement, Fisher will have access to the CardioChek test system, which provides on-site ketone, glucose, and lipid panel readings in less than two minutes.

The CardioChek system does not require a venous draw or refrigeration, allowing healthcare providers to offer fast results to patients in a variety of settings.

This new agreement with PTS, Inc. fits with Fisher’s strategic plan to expand its presence within the Point-of-Care Testing (POCT) market.

According to Joyce Trost, Director of National Distribution for PTS, Inc., the agreement grew out of discussions with Fisher in response to an unmet need within the Point of Care Testing market. “Throughout our discussions, it became increasingly apparent that Fisher HealthCare’s expansion into the POCT market and PTS, Inc.’s targeted strategy were in full alignment, thereby significantly enhancing PTS, Inc.’s access to the clinical diagnostic market segments of the IDN and Health System in general.”

Robert Huffstodt, President and CEO of PTS, Inc. said, “We have invested our resources in the design and manufacturing of products to serve the clinical diagnostic market, and our agreement with Fisher HealthCare not only validates our investment, it also solidifies our presence in this market. PTS is proud to be positioned as a global partner for improving health and enhancing wellness, and we are very pleased to be partnering with Fisher HealthCare to improve patient diagnostics.”

The CardioChek test system is FDA-cleared for marketing in the U.S., in accordance with pre-market notification requirements as set forth by the FDA, as well as CLIA-waived. It is also CE-marked for marketing in the European Union.

About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. is the world leader in serving science. Their mission is to enable their customers to make the world healthier, cleaner, and safer. With revenues of $12 billion, Fisher has approximately 39,000 employees and serves pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions, and government agencies, as well as in environmental and process control industries. Their products and services help their customers solve complex analytical challenges, improve patient diagnostics and increase laboratory productivity. Visit for more information.

About Polymer Technology Systems, Inc. (PTS, Inc.)
Polymer Technology Systems, Inc. (PTS, Inc.) is a global provider of point-of-care diagnostic products to the healthcare industry. Headquartered in Indianapolis, Indiana, PTS, Inc. manufactures products for distribution in over 120 countries around the world with sales offices in Europe, Latin America, and the Pacific Rim.

PTS, Inc. products include the CardioChek® PA point-of-care device and the CardioChek Health Risk Assessment (HRA) software, that are marketed to the professional diagnostics industry and the healthcare screening market. The company offers tests for a Lipid Panel, LDL Cholesterol, Glucose, Ketone, and other single and combination test strips for professional use with the CardioChek point-of-care device. Visit the website at

Media contact:
Kathleen Sutton
Director of U.S. Product Management
Polymer Technology Systems, Inc.
Indianapolis, IN

All trademarks used or mentioned in this release are protected by law.

LIT001566 Rev. 0 11/12